Company

Last deal

Amount

Series C

Stage

15.06.2024

Date

all rounds

$158.8M

Total amount

MAXVAX is focused on revolutionizing the field of vaccine development and bringing innovative vaccines to market.

Industry

Sector :

Subsector :

Keywords :

Also Known As

MaxHealth Biotechnology

founded date

01.01.2016

Number of employees

Last funding type

Series C

IPO status

Private

Description

MAXVAX is dedicated to revolutionizing the process of creating and bringing new vaccines to market.

location

Phone number

Website URL